(Reuters) - A unit of medical device maker Medtronic plc must pay $106.5 million to competitor Colibri Heart Valve LLC for patent infringement, a Santa Ana, California federal jury said Wednesday. The ...

The US Court of Appeals has overturned a $106.5m ruling wherein a California court jury found that Medtronic infringed on a heart valve replacement method developed by Colibri Heart Valve. Colibri ...

A federal jury in California said Wednesday that a unit of Medtronic must pay $106.5 million to competitor Colibri Heart Valve LLC for patent infringement. After a seven-day trial in Santa Ana, Calif.

A federal appeals court has sided with Medtronic Plc (NYSE:MDT) in a long-running patent dispute, reversing a jury's finding that the company induced infringement of a Colibri Heart Valve LLC patent ...

These patients were enrolled under the rigorous "real world" Medtronic CoreValve ADVANCE Study. This transcatheter aortic valve implantation (:TAVI) study reported low rates of mortality and stroke, ...

Medtronic announced new findings from the Medtronic CoreValve ADVANCE Study for 1-year survival and health-related quality of life, or HRQoL. The findings were presented this week at Transcatheter ...

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The company also received ...

TCT 122: Perioperative and In-Hospital Outcomes of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample 2016-2021 Receive the ...

WASHINGTON, March 29 (Reuters) - Medtronic Inc's minimally invasive CoreValve system for replacing diseased aortic heart valves led to a significantly higher survival rate after one year than ...

The new chief executive of Medtronic Inc., the Minneapolis medical device maker with 700 Orange County workers, has a challenge on his hands. Omar Ishrak, a former executive at GE Healthcare Inc., was ...